哈药股份
(600664)
| 流通市值：93.94亿 | | | 总市值：93.94亿 |
| 流通股本：25.19亿 | | | 总股本：25.19亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,124,702,491.09 | 4,174,424,028.39 | 16,175,856,239.24 | 12,256,440,508.95 |
| 营业收入 | 8,124,702,491.09 | 4,174,424,028.39 | 16,175,856,239.24 | 12,256,440,508.95 |
| 二、营业总成本 | 7,724,597,864 | 3,907,797,043.17 | 15,304,315,131.09 | 11,561,514,820.89 |
| 营业成本 | 5,927,433,454.75 | 3,061,636,859.52 | 11,607,227,744.2 | 8,796,789,715.71 |
| 税金及附加 | 62,808,028.55 | 32,425,072.35 | 125,561,578.44 | 96,253,591.76 |
| 销售费用 | 1,257,536,286.52 | 582,635,212.56 | 2,561,922,958.87 | 1,965,792,933.38 |
| 管理费用 | 396,417,371.94 | 192,564,664.79 | 836,122,858.85 | 595,629,906.67 |
| 研发费用 | 60,070,516.54 | 31,122,681.26 | 136,434,672.73 | 81,093,964.69 |
| 财务费用 | 20,332,205.7 | 7,412,552.69 | 37,045,318 | 25,954,708.68 |
| 其中:利息费用 | 20,741,080.24 | 10,533,258.03 | 60,067,602.8 | 41,796,080.06 |
| 其中:利息收入 | 17,160,464.37 | 6,629,528.8 | 37,028,958.35 | 26,518,277.53 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | - | 0 |
| 加:投资收益 | - | - | 12,437,230.26 | 12,786,380.38 |
| 净敞口套期收益 | - | - | - | 0 |
| 汇兑收益 | - | - | - | 0 |
| 资产处置收益 | 3,985,875.71 | 1,563,746.69 | 1,032,392.61 | 887,473.94 |
| 资产减值损失(新) | -16,519,763.68 | 0 | -100,066,623.53 | -12,045,848.65 |
| 信用减值损失(新) | -41,831,461.24 | -8,776,021.8 | 39,372,000.69 | -22,751,656.34 |
| 其他收益 | 20,516,338.38 | 12,640,227.49 | 65,888,807.23 | 47,823,011.54 |
| 四、营业利润 | 366,255,616.26 | 272,054,937.6 | 890,204,915.41 | 721,625,048.93 |
| 加:营业外收入 | 1,429,728.41 | 217,180.13 | 5,098,942.71 | 3,827,160.4 |
| 减:营业外支出 | 5,761,313.09 | 595,007.19 | 20,297,752.32 | 14,759,496.41 |
| 五、利润总额 | 361,924,031.58 | 271,677,110.54 | 875,006,105.8 | 710,692,712.92 |
| 减:所得税费用 | 98,044,757.83 | 52,951,619.53 | 184,398,274.21 | 162,944,528.15 |
| 六、净利润 | 263,879,273.75 | 218,725,491.01 | 690,607,831.59 | 547,748,184.77 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 263,879,273.75 | 218,725,491.01 | 690,607,831.59 | 547,748,184.77 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 259,705,144.23 | 212,929,359.73 | 628,846,598.33 | 508,286,408.86 |
| 少数股东损益 | 4,174,129.52 | 5,796,131.28 | 61,761,233.26 | 39,461,775.91 |
| 扣除非经常损益后的净利润 | 244,155,901.1 | 203,986,037.99 | 585,820,306.77 | 470,126,870.18 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.1 | 0.08 | 0.25 | 0.2 |
| (二)稀释每股收益 | 0.1 | 0.08 | 0.25 | 0.2 |
| 八、其他综合收益 | 476,694.89 | 14,226.63 | -3,156,731.76 | 399,007.61 |
| 归属于母公司股东的其他综合收益 | 476,694.89 | 14,226.63 | -3,156,731.76 | 399,007.61 |
| 九、综合收益总额 | 264,355,968.64 | 218,739,717.64 | 687,451,099.83 | 548,147,192.38 |
| 归属于母公司股东的综合收益总额 | 260,181,839.12 | 212,943,586.36 | 625,689,866.57 | 508,685,416.47 |
| 归属于少数股东的综合收益总额 | 4,174,129.52 | 5,796,131.28 | 61,761,233.26 | 39,461,775.91 |
| 公告日期 | 2025-08-23 | 2025-04-26 | 2025-04-26 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |